Has Michael Jessen, MD received payments from drug or device companies?

Yes. Drug and device makers reported $21,036 in general payments to Michael Jessen, MD across 99 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Michael Jessen, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Michael Jessen, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Michael Jessen, MD

Thoracic Surgery (Cardiothoracic Vascular Surgery) · Dallas, TXNPI 1275597015

Payments from drug & device makers

What this record shows

The money is spread across several categories — travel and lodging (35.5%), food and beverage and speaking fees — rather than concentrated in one kind of arrangement. 19 manufacturers reported payments, led by Philips North America LLC at 47.0% of the total. 2025 is the largest year on record at $9,643, 4.2 times the $2,289 reported in 2019.

$21,036in general payments, 2019–2025

Across 99 payments — averaging $212.49 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Philips North America LLC$10K
Edwards Lifesciences$4K
Cerus Corporation$3K
AstraZeneca$1K
Medtronic$1K
Baxter Healthcare$629
plus $1K from 13 others

$155,578in research payments, 2019–2025

Across 8 payments — averaging $19,447 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Artivion, Inc.$75K
Novartis$61K
AstraZeneca$20K

What the payments were for

Speaking & faculty fees$5,40026%
Grants$8004%
Travel & lodging$7,47036%
Food & beverage$7,36635%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Philips North America LLC	20	$9,885
Edwards Lifesciences	34	$3,676
Cerus Corporation	2	$2,621
AstraZeneca	9	$1,379
Medtronic(2 entities)	6	$1,379
Baxter Healthcare	9	$629
Intuitive Surgical	2	$458
Bolton Medical Inc	2	$215
Artivion, Inc.	1	$197
Atricure, Inc.	4	$193
Kls-martin L.p.	2	$164
Zimmer Biomet	1	$56
Getinge USA Sales, LLC	1	$52
Lemaitre Vascular, Inc.	1	$36
Genentech, Inc.	1	$31
Lidco Group PLC	1	$21
Abiomed	1	$21
Abbott	1	$20
ZOLL Circulation Inc	1	$4

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

(9520) IGT Devices Undivided$6,922
INTERCEPT BLOOD SYSTEM FOR PLATELETS$2,621
IGT Devices Und$1,549
ULTOMIRIS$1,167
(9124) LM Undivided$941
ENDURANT IIS$800
Da Vinci Surgical System$439
INSPIRIS RESILIA aortic valve$326
MITRIS RESILIA Mitral Valve$311
CoreValve Evolut$300
No Related Product$254
BioGlue$197
PerClot$197
SAPIEN 3 Ultra RESILIA$148
ATRICURE ATRICLIP LAA EXCLUSION$132
ATRICURE SYNERGY ABLATION SYSTEM$132
3F$129
EDWARDS INTUITY Elite valve system$128
TREO ABDOMINAL STENT-GRAFT SYSTEM$125
KONECT RESILIA$125

How this compares

$21,036 in reported general payments places this provider in the 75th percentile of 424 thoracic surgery (cardiothoracic vascular surgery) providers in Texas.

See all thoracic surgery (cardiothoracic vascular surgery) providers in Texas →

Medicare billing

Part B allowed, 2024

$107,827

Medicare patients

142

Services billed

283

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other thoracic surgery (cardiothoracic vascular surgery) in Dallas

Robert HebelerDallas$723K
Michael WaitDallas$187K
Juan MachannafordDallas$164K
Aldo Rafael-YarihuamanDallas$142K
Todd DeweyDallas$128K
Gary SchwartzDallas$77K
Jaye WestonDallas$70K
Brandon HillDallas$53K
Ryan DaviesDallas$51K
Dan MeyerDallas$47K

See the full list for Texas →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →